Monilia Sitophila
Generic Name: monilia sitophila
Brand Names:
Monilia
Dosage form: INJECTION. Route: CUTANEOUS, INTRADERMAL, SUBCUTANEOUS. Active ingredients: CHRYSONILIA SITOPHILA (.1 g/mL). Category: BLA.
Overview
Dosage form: INJECTION. Route: CUTANEOUS, INTRADERMAL, SUBCUTANEOUS. Active ingredients: CHRYSONILIA SITOPHILA (.1 g/mL). Category: BLA.
Dosage
Available as injection for cutaneous, intradermal, subcutaneous use.
Related Medications
Palonosetron Hydrochloride
palonosetron hydrochloride
11 DESCRIPTION Palonosetron hydrochloride injection contains palonosetron as palonosetron HCl, an antiemetic and antinauseant agent. It is a serotonin-3 (5-HT 3 ) receptor antagonist with a strong binding affinity for this receptor. Chemically, palonosetron hydrochloride is: (3a S )-2-[( S )-1-Azabicyclo [2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1-oxo-1 H benz[ de ]isoquinoline hydrochloride. The molecular formula is C 19 H 24 N 2 O•HCl, with a molecular weight of 332.87.
Haemophilus B Conjugate Vaccine (tetanus Toxoid Conjugate)
haemophilus b conjugate vaccine (tetanus toxoid conjugate)
Dosage form: KIT. Category: BLA.
Atrasentan
atrasentan
11 DESCRIPTION VANRAFIA contains atrasentan, an endothelin type A (ET A ) receptor antagonist. The chemical name of atrasentan hydrochloride is (2 R , 3 R , 4 S )-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic acid hydrochloride. Atrasentan hydrochloride has a molecular weight of 547.09 g/mol, a molecular formula of C 29 H 38 N 2 O 6 HCl and the following structural formula.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.